Skip to main content

Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.

Publication ,  Journal Article
Sun, X; Nichols, HB; Tse, C-K; Bell, MB; Robinson, WR; Sherman, ME; Olshan, AF; Troester, MA
Published in: Cancer Epidemiol Biomarkers Prev
January 2016

BACKGROUND: Parity and time since last birth influence breast cancer risk and vary by intrinsic tumor subtype, but the independent effects of these factors on prognosis have received limited attention. METHODS: Study participants were 1,140 invasive breast cancer patients from phases I and II of the population-based Carolina Breast Cancer Study, with tissue blocks available for subtyping using immunohistochemical markers. Breast cancer risk factors, including pregnancy history, were collected via in-person interviews administered shortly after diagnosis. Vital status was determined using the National Death Index. The association of parity and birth recency with breast cancer-specific and overall survival was assessed using Cox proportional hazards models. RESULTS: During follow-up (median = 13.5 years), 450 patients died, 61% due to breast cancer (n = 276). High parity (3+ births) and recent birth (<5 years before diagnosis) were positively associated with breast cancer-specific mortality, independent of age, race, and selected socioeconomic factors [parity, reference = nulliparous, adjusted HR = 1.76; 95% confidence interval (CI) = 1.13-2.73; birth recency, reference = 10+ years, adjusted HR = 1.29; 95% CI, 0.79-2.11]. The associations were stronger among patients with luminal tumors and those surviving longer than 5 years. CONCLUSIONS: Parity and recent birth are associated with worse survival among breast cancer patients, particularly among luminal breast cancers and long-term survivors. IMPACT: The biologic effects of parity and birth recency may extend from etiology to tumor promotion and progression.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

January 2016

Volume

25

Issue

1

Start / End Page

60 / 67

Location

United States

Related Subject Headings

  • Young Adult
  • Survival Rate
  • Reproductive History
  • Receptors, Progesterone
  • Receptors, Estrogen
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Prognosis
  • Pregnancy
  • Parity
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sun, X., Nichols, H. B., Tse, C.-K., Bell, M. B., Robinson, W. R., Sherman, M. E., … Troester, M. A. (2016). Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev, 25(1), 60–67. https://doi.org/10.1158/1055-9965.EPI-15-0864
Sun, Xuezheng, Hazel B. Nichols, Chiu-Kit Tse, Mary B. Bell, Whitney R. Robinson, Mark E. Sherman, Andrew F. Olshan, and Melissa A. Troester. “Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.Cancer Epidemiol Biomarkers Prev 25, no. 1 (January 2016): 60–67. https://doi.org/10.1158/1055-9965.EPI-15-0864.
Sun X, Nichols HB, Tse C-K, Bell MB, Robinson WR, Sherman ME, et al. Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):60–7.
Sun, Xuezheng, et al. “Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.Cancer Epidemiol Biomarkers Prev, vol. 25, no. 1, Jan. 2016, pp. 60–67. Pubmed, doi:10.1158/1055-9965.EPI-15-0864.
Sun X, Nichols HB, Tse C-K, Bell MB, Robinson WR, Sherman ME, Olshan AF, Troester MA. Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype. Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):60–67.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

January 2016

Volume

25

Issue

1

Start / End Page

60 / 67

Location

United States

Related Subject Headings

  • Young Adult
  • Survival Rate
  • Reproductive History
  • Receptors, Progesterone
  • Receptors, Estrogen
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Prognosis
  • Pregnancy
  • Parity